The goal when developing an in vitro-in vivo correlation (IVIVC) model is the ability to accurately predict the in vivo plasma concentration profile of a drug formulation using only its in vitro dissolution data. The prediction accuracy of any model depends on the reliability of the method used to d
Cost prediction models for the comparison of two groups
β Scribed by Andrew R. Willan; Bernie J. O'Brien
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 56 KB
- Volume
- 10
- Category
- Article
- ISSN
- 1057-9230
- DOI
- 10.1002/hec.615
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
For trialβbased economic evaluation where patientβspecific cost data are not routinely available, cost prediction models are commonly used to estimate total cost for each patient. Typically, multiple regression techniques are used on data from diagnosisβmatched, nonβtrial patients (where patientβlevel cost data are available) to model cost as a function of covariates that are observed on the trial subjects (e.g. length of hospital stay, procedures, etc.). The estimated beta coefficients provide a means of estimating the total cost for each patient in the trial. However, the variability of the beta coefficients due the measurement and sampling error is seldom included in the overall variance expression for mean costs by treatment group. In this paper we provide a method for estimating this variance and provide an example application Copyright Β© 2001 John Wiley & Sons, Ltd.
π SIMILAR VOLUMES
This issue of Statistics in Medicine contains as the lead article a provocative paper by Alvan Feinstein, &Indexes of contrast and quantitative signi"cance for comparisons of two groups', followed by commentaries by